- CHANGES TO THE BOARD OF DIRECTORS
- SUMMARY OF VOTING RESULTS
Regulatory News:
ORPEA (Paris:ORP):
Guillaume Pepy, Chairman of the Board of Directors:
"ORPEA can now look to the future with a largely new Board of
Directors, reflecting the arrival of its new shareholders. I am
delighted with this new governance structure. The skills of the new
Board of Directors, combined with the long-term vision of our new
shareholders, will give the Group the resources it needs to achieve
its ambitions. Since summer 2022, the Group has been supported by a
Board of Directors working closely with Laurent Guillot and his
team to successfully implement the Refoundation Plan and the
financial restructuring. Once again, I would like to thank the
outgoing directors for their commitment, and on behalf of us all, I
would like to congratulate Laurent Guillot and his team for their
dedication to serving patients, residents and staff. I would also
like to thank the newly appointed members of the Board for their
renewed support and I shall continue to fulfil my role as Chairman
of the Board with commitment and determination, serving all ORPEA's
stakeholders and pursuing the Refoundation work that began over a
year ago".
Laurent Guillot, Chief Executive Officer: "This General
Meeting is a major step in the Refounding of the company. The
arrival of Caisse des Dépôts, CNP, MAIF and MACSF as shareholders
represented on the Board of Directors, is a sign of confidence in
the company, its responsibilities and its vital role in serving the
most vulnerable, and above all in the men and women who serve them
in the field each day. I'm very pleased with this new governance
structure and with the appointment to our Board of Directors of
individuals with recognised experience. I would also like to thank
the outgoing directors for their commitment and support throughout
their tenure, alongside Guillaume Pepy, Chairman of the Board. The
ORPEA Group is today starting a new chapter. Since 15 November
2022, we have been transforming ORPEA with our Refoundation Plan.
We successfully restored the Company's financial balance, with the
Group undergoing profound changes in one year. To improve the
working conditions in our facilities and the care we provide to our
residents, patients and beneficiary, we embarked on a
transformation process and are achieving the first results, but we
need to continue and accelerate. Thanks to the support of the
Board, the commitment of its Chairman Guillaume Pepy, and the
determination of all the Group's team, which I commend, we can
embark on this new phase with confidence and ambition to become a
company with a mission, serving the common interest".
Changes to the Board of Directors of ORPEA
Today's Combined General Meeting of ORPEA (the “Meeting”)
approved the major changes to the Board of Directors of ORPEA
proposed in connection with its financial restructuring, and in
accordance with (i) the Lock-Up agreement, entered into on 14
February 2023 between the Company and, firstly, Caisse des Dépôts
et Consignations, CNP Assurances, MAIF and MACSF (the
“Groupement") and, secondly, five institutions holding the
Company's unsecured debt and (ii) the Company’s accelerated
safeguard plan approved by the specialised commercial court of
Nanterre on 24 July 2023.
Additionally the new Board of Directors, which met immediately
after the Meeting, appointed two non-voting advisors.
Finally, May Antoun was appointed as director representing
employees by the European Works Council of ORPEA at its plenary
meeting of 13 December 2023.
Having regard to the expiry announced on 13 November 2023 of the
terms of office of certain directors who were previously acting,
and to these appointments, the Board of Directors of ORPEA is now
composed of 13 directors and two non-voting advisors,
including:
- seven non-independent directors, namely Caisse des Dépôts et
Consignations (represented by Audrey Girard), CNP Assurances
(represented by Stéphane Dedeyan), MAIF (represented by Pascal
Demurger), MACSF Epargne Retraite (represented by Stéphane
Dessirier), Philippe Grangeon, Sibylle Le Maire and Frédérique
Mozziconacci,
- three independent directors, namely Guillaume Pepy, Mireille
Faugère and Méka Brunel,
- the Chief Executive Officer, namely Laurent Guillot, and
- two directors representing employees, namely Sophie Kalaidjian
and May Antoun.
Three directors on the Board are independent, giving a
proportion of independent directors of 27% (excluding directors
representing employees and non-voting advisors). The composition of
the Board of Directors is not compliant with recommendation 10.3 of
the AFEP-MEDEF Code providing that, in controlled companies, the
proportion of independent directors must be at least one third.
Appendix contains a table providing details and
information about the members of the new Board of Directors.
At its first meeting, the new Board of Directors decided (i) to
create an Investment Committee, (ii) to change the duties of its
four Board Committees and (iii) to determine the new composition of
those Committees.
As of 22 December 2023:
- the Audit and Risks Committee is composed of five
directors: Méka Brunel (Chair), Caisse des Dépôts et Consignations
(represented by Audrey Girard), CNP Assurances (represented by
Stéphane Dedeyan), MAIF (represented by Pascal Demurger) and
Mireille Faugère. Laurent David, non-voting advisor, also attends
this Committee.
Two directors on this Committee are independent, giving a
proportion of independent directors of 40% (excluding non-voting
advisors). The composition of the Audit and Risks Committee is not
compliant with recommendation 17.1 of the AFEP-MEDEF Code providing
that the proportion of independent directors must be at least two
thirds;
- the Appointments and Remuneration Committee is composed
of six directors: Guillaume Pepy (Chair), Caisse des Dépôts et
Consignations (represented by Audrey Girard), MACSF Epargne
Retraite (represented by Stéphane Dessirier), Philippe Grangeon,
Méka Brunel and Sophie Kalaidjian.
Two directors on this Committee are independent, giving a
proportion of independent directors of 40% (excluding the director
representing employees). The composition of the Appointments and
Remuneration Committee is not compliant with recommendations 18.1
and 19.1 of the AFEP-MEDEF Code providing that the committee
responsible for appointments and the committee responsible for
remuneration must be composed of a majority of independent
directors;
- the Ethics, Quality and CSR Committee is composed of
five directors: Mireille Faugère (Chair), Philippe Grangeon,
Sibylle Le Maire, Frédérique Mozziconacci and May Antoun. Pascale
Pradat, non-voting advisor, also attends this Committee.
The AFEP-MEDEF Code does not provide any recommendations
regarding the composition of this Committee;
- the Investment Committee is composed of three
directors: Caisse des Dépôts et Consignations (represented by
Audrey Girard) (Chair), CNP Assurances (represented by Stéphane
Dedeyan) and Philippe Grangeon. Laurent David, non-voting advisor,
also attends this Committee.
The AFEP-MEDEF Code does not provide any recommendations
regarding the composition of this Committee.
The duties of the Board Committees are set out in the Internal
Rules of the Board of Directors, as amended on 22 December 2023,
which are available on ORPEA's website at the following address:
www.orpea-group.com/en/the-group/gouvernance
The failure to comply with the recommendations of the AFEP-MEDEF
Code relating to the proportion of independent directors on the
Board of Directors, the Audit and Risks Committee and the
Appointments and Remuneration Committee is due to the governance
agreed in relation to the Groupement's stake in the Company’s share
capital, having regard to its acquisition of a majority
shareholding, which is set out in the Company's accelerated
safeguard plan approved by the specialised commercial court of
Nanterre on 24 July 2023.
Summary of voting results for other resolutions
During this Meeting, the required majority of Company
shareholders approved the resolutions relating to:
- the approval of the 2022 financial statements, the
appropriation of profit and the approval of the Auditors’ report on
regulated agreements;
- the approval of the co-option of two directors;
- the appointment of new directors;
- the remuneration and benefits of corporate officers for the
2022 financial year (except Yves Le Masne’s remuneration and
benefits1);
- the remuneration policy for corporate officers for the 2023
financial year;
- the renewal or grant of financial delegations and
authorisations to the Board of Directors (except the authorization
to issue share warrants to the Groupement1);
- the amendment of the Articles of Association;
- the powers for formalities.
It should be noted that the shares of the beneficiaries of the
issuance of share warrants without pre-emption rights for
shareholders under the 27th and 28th resolutions were excluded from
the vote on the corresponding resolutions pursuant to applicable
regulations.
Detailed results of the votes may be consulted at this following
address:
www.orpea-group.com/en/shareholders-investors/shareholders/shareholder-meeting
About ORPEA
ORPEA is a leading global player, expert in the care of all
types of frailty. The Group operates in 20 countries and covers
three core businesses: care for the elderly (nursing homes,
assisted living, home care), post-acute and rehabilitation care and
mental health care (specialized clinics). It has more than 76,000
employees and welcomes more than 267,000 patients and residents
each year.
https://www.orpea-group.com/en
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and a
member of the SBF 120 and CAC Mid 60 indices.
Appendix
Personal information
Experience
Position on the Board
Membership of
Committees
Director
Age2
Gender
Nationality/Nationalities
Number of shares
Number of offices held in
listed companies
Independence
First date of
appointment
Term of office3
Length of service on the
Board
(C = Chair /
M = Member)
Guillaume Pepy
65
M
French
1
2
Yes
28/07/2022
AGM 2026
2
Appointments and Remuneration
Committee (C)
Laurent Guillot
54
M
French
1
2
No
28/07/2022
AGM 2026
1
-
Audrey Girard4
48
F
French
-
0
No
22/12/2023
AGM 2026
0
Investment Committee (C)
Audit and Risk Committee (M)
Appointments and Remuneration Committee (M)
Stéphane Dedeyan5
58
M
French
-
3
No
22/12/2023
AGM 2027
0
Audit and Risk Committee (M)
Investment Committee (M)
Pascal Demurger6
59
M
French
-
0
No
22/12/2023
AGM 2027
0
Audit and Risk Committee (M)
Stéphane Dessirier7
63
M
French
-
0
No
22/12/2023
AGM 2026
0
Appointments and Remuneration
Committee (M)
Philippe Grangeon8
66
M
French
-
1
No
22/12/2023
AGM 2027
0
Ethics, Quality and CSR Committee
(M) Appointments and Remuneration Committee (M)
Investment Committee (M)
Sibylle Le Maire8
49
F
French
-
1
No
22/12/2023
AGM 2027
0
Ethics, Quality and CSR Committee
(M)
Frédérique Mozziconacci9
51
F
French
-
1
No
22/12/2023
AGM 2026
0
Ethics, Quality and CSR Committee
(M)
Méka Brunel
67
F
French
70,000
1
Yes
22/12/2023
AGM 2027
0
Audit and Risk Committee (C)
Appointments and Remuneration
Committee (M)
Mireille Faugère
67
F
French
1
1
Yes
01/10/2022
AGM 2024
1
Audit and Risk Committee (M)
Ethics, Quality and CSR Committee (C)
Sophie Kalaidjian
45
F
French
20
1
No
15/01/2015
AGM 2024
8
Appointments and Remuneration
Committee (M)
May Antoun
63
F
French
-
0
No
13/12/2023
AGM 2026
0
Ethics, Quality and CSR Committee
(M)
Non-voting members
Age2
Gender
Nationality/Nationalities
Number of shares
Number of offices held in
listed companies
Independence
First date of
appointment
Expiry date of term of
office
Length of service on the
Board
Chairman (C) / Member
(M)
Laurent David
36
M
French and British
-
0
-
22/12/2023
AGM 2027
0
Audit and Risk Committee (M)
Investment Committee (M)
Pascale Pradat
64
F
French
-
0
-
22/12/2023
AGM 2027
0
Ethics, Quality and CSR Committee
(M)
__________________
1 The 17 resolution relating to the 2022 remuneration for Yves
Le Masne and the 27th resolution relating to the delegation of
powers to the Board of Directors to issue and allocate share
warrants to the Groupement were rejected, with 11.19% of favorable
votes and 65.55% of favorable votes respectively. 2On the date of
publication of the 2023 notice of meeting brochure. 3General
Meeting ruling on the financial statements for the previous
financial year. 4Permanent representative of the Caisse des Dépôts
et Consignations. 5Permanent representative of CNP Assurances.
6Permanent representative of MAIF. 7Permanent representative of
MACSF Epargne Retraite. 8Candidate proposed by Caisse des Dépôts et
Consignations. 9 Candidate proposed by MAIF.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231222627505/en/
Investor Relations ORPEA Benoit Lesieur Investor
Relations Director b.lesieur@orpea.net
Toll-free number for shareholders: 0 805 480 480
Investor Relations NewCap Dusan Oresansky 01 44 71
94 94 ORPEA@newcap.eu
Press Relations ORPEA Isabelle Herrier-Naufle
Press Relations Director 07 70 29 53 74 i.herrier-naufle@orpea.net
Image7 Charlotte Le Barbier // Laurence Heilbronn 06 78
37 27 60 - 06 89 87 61 37 clebarbier@image7.fr lheilbronn@image7.fr
Orpea (EU:ORP)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Orpea (EU:ORP)
Historical Stock Chart
Von Apr 2023 bis Apr 2024